NURS 403 – Pathophysiology/Pharmacology I Quiz 4 Study Sheet – Drug List
Module 6, Lectures 1-4
Module 6: Cardiovascular System
Drugs for Hypertension (Chapter 47)
1. Diuretics: (Ch. 41)
• MOA: block Na & Cl reabsorption → ↓ passive reabsorption of H2O causing larger amount of H2O and Na to be
excreted in urine
o Urinary Output: will be equivalent to the amount of Na & Cl reabsorption blocked; diuretics acting on
earlier reabsorption sites in the nephron (PCT) will have higher diuretic effect than diuretics acting on
later reabsorption sites of the nephron (DCT & collecting duct)
• Risks: Hypovolemia and Electrolyte/acid-base imbalances
o More risk with Long-acting agents vs short-acting
o Risk is also dependent on administration timing (kidney operation b/w diuresis)
A. Thiazide Diuretics: Hydrochlorothiazide
o MOA: act on early segment DCT to decrease blood volume (initial) and induce vasodilation which
decreases arterial resistance (long-term)
o Uses: 1st line option for HTN compared to CCBs, ACE-I
▪ Renal Function: MUST be good to use thiazides – if GFR < 15-20mL/min, thiazides will be
ineffective and should be avoided
o ADEs:
▪ Electrolyte Loss: hypokalemia, hyponatremia, hypochloremia, hypomagnesemia → replace
▪ Nocturia: need to urinate during the night → Tx early in the day
▪ Dehydration: dry mouth, polydipsia, oliguria
▪ ↑ uric acid: asymptomatic initially; can increase gout attacks in gout pts
▪ ↑ glucose: be aware for diabetic pts
▪ ↑ lipids: be aware for dyslipidemia pts
▪ Pregnancy: avoid
o Interactions:
▪ Digoxin: with hypokalemia caused by thiazide → digoxin toxicity
▪ Lithium: with hyponatremia caused by thiazide → lithium toxicity
▪ NSAIDs: counteract diuresis → avoided; (Tylenol as an alternative)
B. Loop Diuretics: Furosemide
o MOA: act on the ascending loop of Henle to cause profound diuresis (>thiazides)
▪ Onset: is rapid (5min if IV, 60min if PO)
o Uses: Not routinely 1st line for HTN; used as an add-on when thiazide on its own was ineffective; DOC for
pulmonary edema due to rapid onset via IV administration
▪ Renal Function: loops can be used regardless of renal function
o ADEs: same as thiazides → risk of dehydration & electrolyte imbalance; avoid in pregnant pts
▪ Unique to Loops: hypocalcemia & ototoxicity
o Interactions: same as thiazides; be aware of other ototoxic agents (vancomycin, aminoglycosides)
C. K-Sparing Diuretics: Spironolactone (also classified as an aldosterone antagonist)
o MOA: inhibits normal action of aldosterone on distal nephron, thereby causing Na & H2O excretion & K
retention; effects are delayed, as no profound diuresis is produced for up to 48h
o Uses: due to slow onset, only used as add-ons to loop/thiazide Tx to prevent hypokalemia; not used by
itself as a diuretic agent
o ADEs:
▪ Hyperkalemia: due to “K-sparing” action
▪ Endocrine Abnormalities: can be caused by drug’s ability to bind to other steroid receptors
(reversible upon D/C)
o Interactions: avoid KCL & salt substitutes (hyperkalemia) and RAAS agents & other aldosterone
antagonists (deregulates aldosterone action)
D. Osmotic Diuretics: Mannitol (a diuretic not used for hypertension)
o MOA: not reabsorbed and remains in nephron to create an osmotic force which inhibits passive
reabsorption of H2O; has no effect on electrolytes (unique to osmotics)
o Uses: Tx of increased intracranial or intraocular pressure (i.e., cerebral edema); prophylaxis of renal
failure; Administration is IV only
o ADEs: avoid in patients presenting with CHF, HD, pulmonary edema
, 2. Drugs Acting on Adrenergic Receptors: (α & β Receptors)
A. Beta Blockers: (Ch. 18)
• MOA: blocks sympathetic nervous system action on the β-receptors (β1 or β2)
o β1 Blockade: decreases HR, heart contractility and cardiac output
o Vasodilation action: causes suppression of reflex tachycardia
o Juxtaglomerular Cell action: decreases renin, which decreases
vasoconstriction (ATII) and volume expansion (aldosterone)
o Long-term use: decreases peripheral resistance
• Efficacy: Caucasians > African Americans
i. β1-selective agents: metoprolol, atenolol (only affect the heart)
o Lipid solubility: metoprolol
o ADEs:
▪ Bradycardia: due to ↓ AV node conduction & contractility; patients with sinus bradycardia,
2nd or 3rd Degree AV Block, or HF should avoid → opt for ISA instead
▪ Masking of Hypoglycemia: by preventing tachycardia that usually accompanies
hypoglycemia; patients with diabetes should be cautious or avoid
▪ Rebound Excitation: caused by abrupt d/c of β-Blocker; presents as angina, & ventricular
dysrhythmia → temporarily resume drug therapy and then gradual titrate down over 1-2w
▪ CNS: (rare) depression, insomnia, bizarre dreams can sometimes occur – typically with lipid-
soluble agents
ii. Non-selective agents (β1 or β2): propranolol, carvedilol, labetalol (affect the heart and the lungs)
o Lipid solubility: propranolol
o Vasodilation: carvedilol, labetalol (block Alpha and Beta receptors)
o ADEs:
▪ Bronchoconstriction: due to non-selective action of drug on the lungs; patients with asthma
or COPD should avoid
▪ Hypoglycemia: due to β2 blockage of glycogen→glucose process; patients with diabetes
taking insulin should avoid → opt for selective agent for DM patients
▪ Rebound Excitation and CNS effects: same as β1-selective agents
o Interactions:
▪ Rebound Excitation and CNS effects: same as β1-selective agents
▪ Epinephrine: non-selective agents will inhibit action of epinephrine and should be avoided in
patients with history of anaphylaxis → opt for selective agent
▪ Ca Channel Blockers: avoid verapamil & diltiazem with propranolol due to potentiative
effects
▪ Insulin: non-selective agents will cause hypoglycemia in DM patients taking insulin due to
potentiative effects → opt for selective agent
iii. Intrinsic Sympathomimetic Activity: (ISA) acebutolol, pindolol; block β-receptors from action of strong
agonists (i.e., NE), but also have mild, partial β-agonism causing less resting bradycardia and less reduction in
cardiac output; Useful if symptomatic bradycardia patients
B. Alpha-1 Blockers: (Ch. 18) prazosin, doxazosin, terazosin
• MOA: blocks the sympathetic action of Alpha-1 receptors to prevent them from inducing vasoconstriction,
resulting in vasodilation
o Arterial dilation: via direct action, results in decreased arterial pressure and peripheral resistance
o Venous dilation: via indirect action, results in decreased venous return, cardiac output and arteriole
pressure
• ADEs:
o Orthostatic hypotension
o Reflex tachycardia: caused by vasodilation lowering BP which triggers baroreceptor reflex →
counteract with β-blocker
o Sexual dysfunction: due to blockage of Alpha-1 which is responsible for ejaculation → reversible
upon d/c
o Nasal congestion: due to vasodilation in nasal mucosa
o Na & H2O retention: decreased BP causes decreased renal blood flow as a compensatory
mechanism, leading to increased BV → Add-on a diuretic
2
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller LEARNEXAMS. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $30.49. You're not tied to anything after your purchase.